Controlling Polymersome Size through Microfluidic-Assisted Self-Assembly: Enabling 'Ready to Use' formulations for biological applications

Anouk Martin (1) , Pierre Lalanne (1) , Amélie Vax (1) , Angela Mutschler (1) , Sebastien Lecommandoux (1)

1 Team 3 LCPO : Polymer Self-Assembly & Life Sciences

The self-assembly of poly(ethylene glycol)-block-poly(trimethylene carbonate) PEG-b-PTMC copolymers into vesicles, also referred as polymersomes, was evaluated by solvent displacement using microfluidic systems. Two microfluidic chips with different flow regimes (micromixer and Herringbone) were used and the impact of process conditions on vesicle formation was evaluated. As polymersomes are sensitive to osmotic variations, their preparation under conditions allowing their direct use in biological medium is of major importance. We therefore developed a solvent exchange approach from DMSO (Dimethylsulfoxide) to aqueous media with an osmolarity of 300 mOsm.L-1, allowing their direct use for biological evaluation. We evidenced that the organic/aqueous solvent ratio does not impact vesicle size, but the total flow rate and copolymer concentration have been observed to influence the size of polymersomes. Finally, nanoparticles with diameters ranging from 76 nm to 224 nm were confirmed to be vesicles through the use of multi-angle light scattering in combination with cryo-TEM (Cryo-Transmission Electron Microscopy) characterization.

Mots clés: Microfluidic; polymersomes; size control; self-assembly; nanomedicine

Domaines: Polymères; Pharmacie galénique

Anouk Martin, Pierre Lalanne, Amélie Vax, Angela Mutschler, Sebastien Lecommandoux. Controlling Polymersome Size through Microfluidic-Assisted Self-Assembly: Enabling 'Ready to Use' formulations for biological applications. International Journal of Pharmaceutics, In press, 642, ⟨10.1016/j.ijpharm.2023.123157⟩. ⟨hal-04136854⟩